Nov 19, 2020 | News, Regulatory
The Agency for Medicines and Health Products, the Spanish health regulator, has just approved the trial of the second segment of Phase 3 for Johnson & Johnson COVID-19 vaccine in 9 hospitals across the country. The New Brunswick based... 
Jul 31, 2020 | News, Regulatory
The FDA approved today of (7/31) RedHill Biopharma’s, a specialty pharmaceutical company headquartered in Israel, investigational new drug (IND) application for phase 3 of RHB-204 in adults with pulmonary nontuberculous myobacteria (NTM) disease....
